{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:21:53Z","timestamp":1715588513298},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1038\/sj.bjc.6600588","type":"journal-article","created":{"date-parts":[[2002,10,16]],"date-time":"2002-10-16T10:59:50Z","timestamp":1034765990000},"page":"938-944","source":"Crossref","is-referenced-by-count":15,"title":["A phase III placebo-controlled study in advanced head and neck cancer using intratumoural cisplatin\/epinephrine gel"],"prefix":"10.1038","volume":"87","author":[{"given":"J A","family":"Werner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Kehrl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Pluzanska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K M","family":"Lavery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Glaholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Dyckhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Maune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M E","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E K","family":"Orenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R D","family":"Leavitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2002,10,21]]},"reference":[{"key":"BF6600588_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1177\/019459989811800412","volume":"118","author":"HA Burris III","year":"1998","unstructured":"Burris III HA, Vogel CL, Castro D, Mishra L, Schwarz M, Spenser S, Oakes DD, Korey A, Orenberg EK (1998) Intratumoural cisplatin\/epinephrine-injectable gel as a palliative treatment for accessible solid tumors. A multicenter pilot study. Head Neck Surg 118: 496\u2013503","journal-title":"Head Neck Surg"},{"key":"BF6600588_CR2","volume-title":"Manual for the Functional Assessment of Cancer Therapy (FACT) Measurement System (version 3).","author":"DF Cella","year":"1993","unstructured":"Cella DF (1993) Manual for the Functional Assessment of Cancer Therapy (FACT) Measurement System (version 3). Chicago: Rush Medical Center"},{"key":"BF6600588_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/oxfordjournals.annonc.a058906","volume":"5","author":"M Clavel","year":"1994","unstructured":"Clavel M, Vermorken JB, Cognetti F, Cappalaere P, de Mulder PH, Schomagel JH, Tueni EA, Verweij J, Wildiers J, Clerico M, Dalesio O, Kirkpatrick A, Snow GB (1994) Randomized comparison of cisplatin, methotrexate, bleomycin, and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck: a phase III study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol 5: 521\u2013526","journal-title":"Ann Oncol"},{"key":"BF6600588_CR4","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650\u20131659","journal-title":"N Engl J Med"},{"key":"BF6600588_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1200\/JCO.1992.10.8.1245","volume":"10","author":"AA Forastiere","year":"1992","unstructured":"Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, Kish JA, McClure S, VonFeldt E, Williamson SK, Von Hoff DD (1992) Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. J Clin Oncol 10: 1245\u20131251","journal-title":"J Clin Oncol"},{"key":"BF6600588_CR6","doi-asserted-by":"crossref","unstructured":"Harbord M, Dawes RFH, Giovannini M, Eysselein V, Mishra L, Orenberg EK, Bown SG (2002) Palliation of dysphagia in advanced esophageal cancer by endoscopic injection of cisplatin\/epinephrine injectable gel. Gastrointest Endosc 6: (in press)","DOI":"10.1067\/mge.2002.129212"},{"key":"BF6600588_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/1097-0142(19890201)63:3<423::AID-CNCR2820630304>3.0.CO;2-C","volume":"63","author":"KA Havlin","year":"1989","unstructured":"Havlin KA, Khun JG, Meyers JW, Ozols RF, Mattox DE, Clark GM, von Hoff DD (1989) High-dose cisplatin for locally advanced or metastatic head and neck cancer. Cancer 63: 423\u2013427","journal-title":"Cancer"},{"key":"BF6600588_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/oxfordjournals.annonc.a059054","volume":"6","author":"MH Huber","year":"1995","unstructured":"Huber MH, Lippman SM, Benner SE, Shirinian M, Dimery IW, Earley CL, Winn RJ, Brooks J, Baez L, Hong WK (1995) Phase II study of carboplatin and continuous infusion bleomycin followed by cisplatin and 5-fluorouracil in recurrent head and neck cancer. Ann Oncol 6: 83\u201385","journal-title":"Ann Oncol"},{"key":"BF6600588_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1200\/JCO.1992.10.2.257","volume":"10","author":"C Jacobs","year":"1992","unstructured":"Jacobs C, Lyman G, Velez-Garcia E, Sridhar KS, Knight W, Hochster H, Goodnough LT, Mortimer JE, Einhorn LH, Schacter L, Cherng N, Dalton T, Burroughs J, Rozencweig M (1992) A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J Clin Oncol 10: 257\u2013263","journal-title":"J Clin Oncol"},{"issue":"Suppl 8","key":"BF6600588_CR10","first-page":"S25","volume":"27","author":"FR Khuri","year":"2000","unstructured":"Khuri FR, Shin DM, Glisson BS, Lippman SM, Hong WK (2000) Treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck: current status and future directions. Semin Oncol 27: Suppl 8 S25\u2013S33","journal-title":"Semin Oncol"},{"issue":"Suppl 6","key":"BF6600588_CR11","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/S0959-8049(01)80579-7","volume":"37","author":"TWT Leung","year":"2001","unstructured":"Leung TWT, Johnson PJ, Vogl TJ, Gores G, Thuluvath PJ and the Clinical Trails Group (2001) Percutaneous loco-regional therapy of unresectable hepatocellular carcinoma with cisplatin\/epinephrine injectable gel. Eur J Cancer 37: Suppl 6 S27","journal-title":"Eur J Cancer"},{"key":"BF6600588_CR12","first-page":"232","volume":"20","author":"J Mackowiak","year":"2001","unstructured":"Mackowiak J, Stewart M, Leavitt R, Burris III H (2001) Validation of the treatment goals questionnaire\u00a9 (TGQ): a new instrument to assess patient benefit following treatment of squamous cell carcinoma of the head and neck (HNSCC) with intratumoral cisplatin\/epinephrine injectable gel. Proc Am Soc Clin Oncol 20: 232","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6600588_CR13","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1002\/1097-0142(20010615)91:12<2369::AID-CNCR1270>3.0.CO;2-3","volume":"91","author":"TSK Mok","year":"2001","unstructured":"Mok TSK, Kanekal S, Ling XR, Leung TWT, Chan ATC, Yeo W, Uy S, Chak K, Leavitt R, Johnson P (2001) Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma. Cancer 91: 2369\u20132377","journal-title":"Cancer"},{"key":"BF6600588_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0016-5107(98)70014-8","volume":"48","author":"SPS Monga","year":"1998","unstructured":"Monga SPS, Wadleigh R, Adib H, Harmon JW, Berlin M, Mishra L (1998) Endoscopic treatment of gastric cancer with intratumoral cisplatin\/epinephrine injectable gel: A case report. Gastrointest Endosc 48: 415\u2013417","journal-title":"Gastrointest Endosc"},{"key":"BF6600588_CR15","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2307\/2531150","volume":"40","author":"A Mu\u00f1oz","year":"1984","unstructured":"Mu\u00f1oz A, Rosner B (1984) Power and sample size for a collection of 2 \u00d7 2 tables. Biometrics 40: 995\u20131004","journal-title":"Biometrics"},{"key":"BF6600588_CR16","unstructured":"North Central Cooperative Oncology Group\/National Cancer Institute (NCCOG\/NCI) (1991) NCCOG\/NCI Toxicity Criteria NCCOG\/NCI: Bethesda"},{"key":"BF6600588_CR17","doi-asserted-by":"crossref","unstructured":"Oratz R, Hauschild A, Sebastain G, Schadendorf D, Castro D, Brocker E-B, Orenberg EK (2002) Intratumoral cisplatin\/epinephrine injectable gel for treatment of patients with cutaneous and soft tissue metastases of malignant melanoma. Melanoma Res (in press)","DOI":"10.1097\/00008390-200302000-00010"},{"key":"BF6600588_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","volume":"355","author":"JP Pignon","year":"2000","unstructured":"Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 355: 949\u2013955","journal-title":"Lancet"},{"key":"BF6600588_CR19","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1200\/JCO.1994.12.10.2113","volume":"12","author":"KT Robbins","year":"1994","unstructured":"Robbins KT, Storniolo AM, Kerber C, Vicario D, Seagren S, Shea M, Hanchett C, Los G, Howell SB (1994) Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 12: 2113\u20132120","journal-title":"J Clin Oncol"},{"key":"BF6600588_CR20","first-page":"283","volume":"69","author":"S Roshon","year":"2001","unstructured":"Roshon S (2001) Control of locally recurrent breast cancer with intratumoral cisplatin\/epinephrine injectable gel. Breast Cancer Res Treat 69: 283","journal-title":"Breast Cancer Res Treat"},{"key":"BF6600588_CR21","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0041-1345(00)02510-0","volume":"33","author":"PJ Thuluvath","year":"2001","unstructured":"Thuluvath PJ, Geschwind JF, Johnson PJ, Heneghan MA, O'Grady J (2001) Management of hepatoma using cisplatin\/epinephrine gel in patients awaiting orthotopic liver transplantation. Transplan Proc 33: 1359\u20131360","journal-title":"Transplan Proc"},{"key":"BF6600588_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/sj.bjc.6600116","volume":"86","author":"TJ Vogl","year":"2002","unstructured":"Vogl TJ, Engelmann K, Mack MG, Straub R, Eichler K, Hochhmuth K, Orenberg E (2002) CT-guided intratumoral administration of cisplatin\/epinephrine gel for treatment of malignant liver tumors. Br J Cancer 86: 524\u2013529","journal-title":"Br J Cancer"},{"key":"BF6600588_CR23","first-page":"620","volume":"19","author":"JA Werner","year":"2000","unstructured":"Werner JA, Castro D, Sridhar KS, Garewal N, Arndt O, Kehrl W, Pluzanska A, Dunphy F, Stewart M (2000) A new instrument to assess improvements in quality of life (QOL) attributed to local control of head and neck squamous cell carcinoma (HNSCC). Proc Am Soc Clin Oncol 19: 620","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF6600588_CR24","first-page":"215","volume":"1","author":"NY Yu","year":"1995","unstructured":"Yu NY, Patawaran MB, Chen JY, Orenberg EK, Brown DM, Luck EE (1995) Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo. Cancer J Sci Am 1: 215\u2013221","journal-title":"Cancer J Sci Am"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6600588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600588","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:45:37Z","timestamp":1684413937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6600588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["BF6600588"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6600588","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}